BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6083910)

  • 1. [Significance of the laboratory diagnosis of hypercoagulability].
    Vorlová Z; Dyr JE
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):450-5. PubMed ID: 6083910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tests for hemostasis and their relevance to venous thrombosis.
    Johnston DW; Scott AA; Glynn MF
    Can J Surg; 1980 Jul; 23(4):373-80. PubMed ID: 6968239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen/fibrin degradation products (FDP/fdp). Characterization, anticoagulant activity, and influence on laboratory assays.
    Arnesen H
    J Oslo City Hosp; 1977 Jun; 27(6):69-80. PubMed ID: 142131
    [No Abstract]   [Full Text] [Related]  

  • 4. [Normal values for hematological and hemostatic parameters in the rabbit. Determination of new parameters for experimental models of thrombosis and hemostasis].
    Monreal L; Anglés AM; Ruiz de Gopegui R; Espada Y; Monasterio J; Roncalés FJ; Monreal M
    Sangre (Barc); 1993 Oct; 38(5):365-9. PubMed ID: 8140497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical significance of fibrinogen degradation products.
    Bick RL
    Semin Thromb Hemost; 1982 Oct; 8(4):302-30. PubMed ID: 6758120
    [No Abstract]   [Full Text] [Related]  

  • 6. Maternal blood haemostatic-fibrinolytic balance and intrauterine growth retardation.
    Ylä-Outinen A; Tuimala R; Koivula T; Pystynen P
    Ann Chir Gynaecol Suppl; 1985; 197():43-5. PubMed ID: 3863530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A typical case of DIC precipitated by cesarean section done for severe toxemia of pregnancy and a follow up laboratory study of the progress of DIC].
    Nishijima S; Nakajima T
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2072-8. PubMed ID: 6512326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation index to distinguish severe preeclampsia from normal pregnancy.
    Kobayashi T; Sumimoto K; Tokunaga N; Sugimura M; Nishiguchi T; Kanayama N; Terao T
    Semin Thromb Hemost; 2002 Dec; 28(6):495-500. PubMed ID: 12536338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypofibrinolysis and thrombophilia].
    Cepelák V; Dvorák J; Cepeláková H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):456-67. PubMed ID: 6083911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation activation markers do not correlate with the clinical risk of thrombosis in pregnant women.
    Bombeli T; Raddatz-Mueller P; Fehr J
    Am J Obstet Gynecol; 2001 Feb; 184(3):382-9. PubMed ID: 11228491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Coagulation tests in septic surgical patients].
    Oberhofer D; Kucisec-Tepes N; Skok J; Vucić N; Cala K
    Acta Med Croatica; 2004; 58(5):389-94. PubMed ID: 15756805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostatic changes associated with normal and abnormal pregnancies.
    Davis GL
    Clin Lab Sci; 2000; 13(4):223-8. PubMed ID: 11586509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are fibrin-related markers useful for the diagnosis of thrombosis?
    Wada H; Sakuragawa N
    Semin Thromb Hemost; 2008 Feb; 34(1):33-8. PubMed ID: 18393141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
    Bremme K; Lind H; Blombäck M
    Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic significance of proteolytic breakdown products of fibrinogen and fibrin].
    Heene DL; Genth K
    Internist (Berl); 1984 Feb; 25(2):93-101. PubMed ID: 6231262
    [No Abstract]   [Full Text] [Related]  

  • 17. [Detection of fibrinogen and fibrin degradation products (FDP) and its clinical significance].
    Fujimaki M; Ikematsu S; Takeuchi I
    Nihon Rinsho; 1973 Apr; 31(4):798-804. PubMed ID: 4580396
    [No Abstract]   [Full Text] [Related]  

  • 18. Hematologic effects of total knee arthroplasty. A prospective evaluation.
    Stern SH; Insall JN
    Clin Orthop Relat Res; 1993 Jan; (286):10-4. PubMed ID: 8425329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nonenzymatic fibrinolysis].
    Dzhurdzhev A; Atanasov K
    Vutr Boles; 1981; 20(3):18-22. PubMed ID: 6455858
    [No Abstract]   [Full Text] [Related]  

  • 20. Coagulation-fibrinolysis is more enhanced in twin than in singleton pregnancies.
    Morikawa M; Yamada T; Turuga N; Cho K; Yamada H; Sakuragi N; Minakami H
    J Perinat Med; 2006; 34(5):392-7. PubMed ID: 16965226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.